Small intestinal bacterial overgrowth (SIBO) has become a significant health problem seen in many clinical practices. The prevalence estimates for SIBO in patients with irritable bowel syndrome (IBS) range from 4-78% (higher prevalence in diarrhea-predominant IBS)1 and is thought to be almost as high in many other disorders of the digestive tract. Defined as an increase in the concentration of bacteria of more than 100,000 colony-forming units per mL in the small intestine, SIBO can lead to malabsorption and malnutrition that…

In this presentation “Novel Clinical Insights on Inflammation: Resolving not Blocking,” Andrew Heyman, MD, MHSA shares clinical experiences and observations related to health conditions associated with increased inflammatory biomarkers. Dr. Heyman explores the role of specialized pro-resolving mediators (SPMs) in the clinical management of chronic inflammatory conditions, such as chronic pain and fibromyalgia, focusing on evidence from a multi-center case series investigation. Dr. Heyman concludes with insights on novel clinical targets for resolvins in neuroinflammation, in addition to providing a…

In this video, Dr. Fergus Shanahan presents “An Overview of the Human Microbiome.” Originally delivered at ASPEN in 2015, this presentation provides a glimpse of success stories in the past with microbiome, as well as a glimpse into the future of using probiotics as preventive and treatment-focused therapies. He chooses to discuss the microbiome as a therapeutic target in the body. He also discusses the use of microbial biomarkers in the body for diagnostic testing. There are very few such…

In this presentation Jaclyn Chasse, ND and President of AANP discusses the role of nutrition in naturopathic medicine and how it has significantly changed over the years for the naturopathic doctor. Dr Chasse points out a few of the key diets that are used in managing nutrition today, among them are the ketogenic diet, the Mediterranean diet and the Paleo diet. She describes the methods many naturopathic doctors use that have had the most impact on improving patient outcomes, including the importance of incorporating phytonutrients…

Dale E Bredesen, MD, is the director of the Easton Center for Alzheimer’s Disease Research at the University of California, Los Angeles (UCLA). He is also the principal investigator in Alzheimer’s Disease at the center. Dr. Bredesen has taken a novel approach to clinical management of cognitive decline by integrating nutrition and lifestyle medicine into practice. Based on his research and clinical practice, we may be entering the era of treatable Alzheimer’s Disease. He also discusses Mild Cognitive Impairment (MCI)…

Robin Walsh, ND discusses the nutritional factors associated with the development of diabetes and obesity. Recent studies have shown that nearly 60% of the population has a genetic predisposition for developing diabetes. Dr. Walsh presents the many factors that lead to carbohydrate intolerance, insulin resistance and diabetic comorbidities. With the development of the 40:30:30 dietary approach created in the Joslin Center guidelines, a balance of macronutrients was shown to be effective in managing elevated blood glucose levels. Recorded at the AANP Pre-Conference in…

There is extensive evidence showing that the intake of healthy fats can reduce incidence of cardiovascular disease (CVD). Dr. Frank Hu of the Harvard T.H. Chan School of Public Health and professor of medicine at Harvard Medical School discusses the evidence from several studies showing the benefits of healthy oils and fats for reduction of CVD incidence and CVD risk factors. Overall recommendations include keeping intake of saturated fatty acids low, replace saturated fat with unsaturated fats, and consume mono-unsaturated…

The purported roles of the microbiota is ever emerging, and the associated technology is rapidly changing, but what do we know today? In this presentation, Mark Lyte, PhD, MS, MT (ASCP) discusses, “The Microbiota-Gut-Brain Axis: Shared Neurochemistry and Its Potential Role in Infection and Behavior.” Dr. Lyte reviews recent literature on the microbiome, taking a long-range view of the microbiome field and where it may be headed. He discusses the microbiota from a neuroendocrine vantage point. Dr. Mark Lyte is…

Chronic inflammatory diseases have root causes that may include gut dysbiosis or leaky gut. Leaky gut syndrome is a proposed condition some health practitioners claim is the cause of a wide range of serious long-term conditions, including diabetes, lupus, and multiple sclerosis. In this webinar, Dr. Robert Martindale discusses the pathology of leaky gut, if it is a real condition, its mechanisms, and treatment opportunities. Proponents of leaky gut syndrome state that an altered or damaged bowel lining or gut…

Part two of Dr. Penny Kris-Etherton’s presentation entitled Clinical Evidence Supporting the Role of Healthy Fats to Reduce Cardiovascular (CVD) Risk Factors is shown in this presentation. Here, Dr. Kris-Etherton discusses more clinical trial evidence regarding the support of unsaturated fatty acids, new research on minor fatty acids, and how these recommendations can be applied to dietary patterns in the real world. The role of the Mediterranean Diet in preventing cardiovascular disease was investigated in several studies, with additional focus…